THC Therapeutics, Inc.: M&A transaction — THC Therapeutics acquires The Headquarters Group in ~$11M all-stock deal

THC Therapeutics, Inc.

Acquired 100% of THG for 11,007 shares of new Series D Preferred stock, valued at ~$11M.
THG subsidiaries include Jefferson Soul, Kalix, NPK Industries, Harvest Food for Life, and real estate; combined 2024 revenue ~$4.8M.
Management cites 60+ years combined experience; plans vertical integration for growth in CA/OR cannabis markets.

item 1.01 item 2.01 item 3.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.95

THC Therapeutics, Inc. completed an acquisition involving The Headquarters Group, Inc. for 11,007 shares of newly created Series D Preferred Stock (closed 2025-06-20).

Action: acquisition
Counterparty: The Headquarters Group, Inc.
Consideration: 11,007 shares of newly created Series D Preferred Stock
Closing: 2025-06-20

Exact text from the filing

On June 20, 2025 the "Company closed the Share Exchange Agreement and acquired 100% of The Headquarters Group, Inc., an Oregon corporation, and its related subsidiaries, in exchange for 11,007 shares of newly created Series D Preferred stock of the Company.

View on SEC.gov

Browse all m&a transactions →

Source: SEC EDGAR

accession 0001477932-25-004827

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.